Oral anticoagulant treatment in very elderly patients with atrial fibrillation.
Many factors can influence the final decision to treat nonrheumatic atrial fibrillation in the very elderly patient with anticoagulants. Therefore, a systemic approach in which the thromboembolic and hemorrhagic risk profiles are taken into account is suggested.
Pengo
V
V
Department of Clinical and Experimental Medicine, Thrombosis Center, University of Padova School of Medicine, Ex Busonera Hospital, via Gattamelata, 64 I-35128 Padova, Italy.
D000284:Administration, Oral; D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D005853:Geriatrics; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D012307:Risk Factors; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D000925:Anticoagulants; D014859:Warfarin